Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0A8HW
|
|||
Former ID |
DNC005132
|
|||
Drug Name |
4-Chloro-N-(5-sulfamoyl-indan-2-yl)-benzamide
|
|||
Synonyms |
CHEMBL364127; 4-Chloro-N-(5-sulfamoyl-indan-2-yl)-benzamide; BDBM50155552
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C16H15ClN2O3S
|
|||
Canonical SMILES |
C1C(CC2=C1C=CC(=C2)S(=O)(=O)N)NC(=O)C3=CC=C(C=C3)Cl
|
|||
InChI |
1S/C16H15ClN2O3S/c17-13-4-1-10(2-5-13)16(20)19-14-7-11-3-6-15(23(18,21)22)9-12(11)8-14/h1-6,9,14H,7-8H2,(H,19,20)(H2,18,21,22)
|
|||
InChIKey |
BJLRENUWWOPZIL-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Carbonic anhydrase I (CA-I) | Target Info | Inhibitor | [1] |
Carbonic anhydrase II (CA-II) | Target Info | Inhibitor | [1] | |
KEGG Pathway | Nitrogen metabolism | |||
Proximal tubule bicarbonate reclamation | ||||
Collecting duct acid secretion | ||||
Gastric acid secretion | ||||
Pancreatic secretion | ||||
Bile secretion | ||||
NetPath Pathway | IL4 Signaling Pathway | |||
EGFR1 Signaling Pathway | ||||
Pathwhiz Pathway | Gastric Acid Production | |||
Pathway Interaction Database | C-MYB transcription factor network | |||
Reactome | Erythrocytes take up carbon dioxide and release oxygen | |||
Erythrocytes take up oxygen and release carbon dioxide | ||||
Reversible hydration of carbon dioxide | ||||
WikiPathways | Reversible Hydration of Carbon Dioxide | |||
Uptake of Carbon Dioxide and Release of Oxygen by Erythrocytes | ||||
Uptake of Oxygen and Release of Carbon Dioxide by Erythrocytes |
References | Top | |||
---|---|---|---|---|
REF 1 | Carbonic anhydrase inhibitors. Design of anticonvulsant sulfonamides incorporating indane moieties. Bioorg Med Chem Lett. 2004 Dec 6;14(23):5781-6. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.